XIFAXAN® (rifaximin) For Adults with Overt HE and IBS-D XIFAXAN® (rifaximin) 550 mg tablets are indicated for the reduction in risk of overt hepatic encephalopathy (HE) recurrence in adults and for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults
Overt Hepatic Encephalopathy Patient Resources - XIFAXAN If your loved one has been prescribed XIFAXAN, this is the place to start This flashcard gives a brief overview about managing overt HE with XIFAXAN, including dosing and savings program details